Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum. 1986

J M Scherrmann, and P Sandouk, and X Guedeney

Digoxin-like immunoreactive substances (DLIS) have been quantified by two different digoxin radioimmunoassays (RIA) in 47 cord sera. The mean DLIS value (in digoxin equivalents) ranged from 0.960 (SD 0.184) to 0.181 (SD 0.104) nmol/L between the two different kits and different lot numbers of the reagents. One of the RIA methods showed an obvious lot-to-lot effect. The use of a longer incubation interval and a higher incubation temperature markedly decreased cross reactions with DLIS. The effect of modifying the incubation conditions in RIA is similar to that described for assays of steroids because the dissociation rates of the immunocomplex play a critical role. Data suggest a specific interaction between DLIS and digoxin antibodies. Control of the incubation conditions is recommended, to decrease or increase the amount of the DLIS in cord serum specimens.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002298 Cardenolides C(23)-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS. Cardenolide
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

J M Scherrmann, and P Sandouk, and X Guedeney
January 1986, Pediatric research,
J M Scherrmann, and P Sandouk, and X Guedeney
April 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine,
J M Scherrmann, and P Sandouk, and X Guedeney
July 2000, European heart journal,
J M Scherrmann, and P Sandouk, and X Guedeney
July 1985, Clinical chemistry,
J M Scherrmann, and P Sandouk, and X Guedeney
March 1993, Zhonghua nei ke za zhi,
J M Scherrmann, and P Sandouk, and X Guedeney
April 1987, Lancet (London, England),
J M Scherrmann, and P Sandouk, and X Guedeney
March 1989, Hepatology (Baltimore, Md.),
J M Scherrmann, and P Sandouk, and X Guedeney
May 1983, Kardiologiia,
J M Scherrmann, and P Sandouk, and X Guedeney
February 1999, Human & experimental toxicology,
Copied contents to your clipboard!